1. Cyclophosphamide‐based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma. Issue 3 (8th October 2014) Authors: Tuchman, Sascha A; Bacon, Wendi A; Huang, Li‐Wen; Long, Gwynn; Rizzieri, David; Horwitz, Mitchell; Chute, John P.; Sullivan, Keith; Morris Engemann, Ashley; Yopp, Amanda; Li, Zhiguo; Corbet, Kelly; Chao, Nelson; Gasparetto, Cristina Journal: Journal of clinical apheresis Issue: Volume 30:Issue 3(2015) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of high‐dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma. Issue 4 (19th January 2017) Authors: Huang, Li‐Wen; Bacon, Wendi; Cirrincione, Constance; Peterson, Bercedis; Long, Gwynn; Rizzieri, David; Sullivan, Keith M.; Corbet, Kelly; Horwitz, Mitchell; Chao, Nelson; Gasparetto, Cristina; Tuchman, Sascha A. Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients. Issue 1 (19th June 2014) Authors: Long, Gwynn; Waller, Edmund K.; Gregurek, Steven; Tricot, Guido; Marschner, Susanne; Bill, Jerry Journal: Journal of clinical apheresis Issue: Volume 30:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma. Issue 3 (May 2017) Authors: Tuchman, Sascha A.; Moore, Joseph O.; DeCastro, Carlos D.; Li, Zhiguo; Sellars, Emily; Kang, Yubin; Long, Gwynn; Gasparetto, Cristina G. Journal: Journal of geriatric oncology Issue: Volume 8:Issue 3(2017) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery. Issue 1 (December 2016) Authors: Green, Michael; Chao, Nelson; Chhabra, Saurabh; Corbet, Kelly; Gasparetto, Cristina; Horwitz, Ari; Li, Zhiguo; Venkata, Jagadish; Long, Gwynn; Mims, Alice; Rizzieri, David; Sarantopoulos, Stefanie; Stuart, Robert; Sung, Anthony; Sullivan, Keith; Costa, Luciano; Horwitz, Mitchell; Kang, Yubin Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗